# Lamivudine and Zidovudine

NDC: 76282-115
Generic name: Lamivudine and Zidovudine
Labeler / Manufacturer: Exelan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20150429

FDA application: ANDA203259

## Active ingredients

- LAMIVUDINE: 150 mg/1
- ZIDOVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76282-115"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76282-115
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4cf565c3-bdec-4c18-93c1-cc7fa8331c90